Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
13.17
+0.39 (3.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Tyra Biosciences Market Cap
Tyra Biosciences has a market cap or net worth of $692.78 million as of February 21, 2025. Its market cap has decreased by -6.72% in one year.
Market Cap
692.78M
Enterprise Value
338.97M
1-Year Change
-6.72%
Ranking
Category
Stock Price
$13.17
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has increased from $654.64M to $692.78M, an increase of 5.83%. That is a compound annual growth rate of 1.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 672.27M | -8.06% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |